Published in J Diabetes Investig on January 21, 2014
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care (1997) 49.11
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA (2001) 8.56
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia (2003) 7.88
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med (2002) 6.32
Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care (2006) 4.72
Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care (2008) 4.32
The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes (2003) 3.23
beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab (2004) 2.91
Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care (2006) 2.34
One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care (2008) 2.13
Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care (2003) 1.91
Pathophysiology of prediabetes. Curr Diab Rep (2009) 1.67
Reduced time points to calculate the composite index. Diabetes Care (2010) 1.56
Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy. Diabetes (2010) 1.53
Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes (2004) 1.53
Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes (2004) 1.51
Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care (2001) 1.44
Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care (2006) 1.42
The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care (2003) 1.38
What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care (2004) 1.29
Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship. Diabetes Care (2007) 1.13
Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose. Diabetes Care (2009) 1.11
The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes. Diabetes Metab Res Rev (2010) 1.05
The utility of fasting glucose for detection of prediabetes. Metabolism (2006) 0.92
Point: postprandial glucose levels are a clinically important treatment target. Diabetes Care (2010) 0.92
Plasma glucose and insulin responses to mixed meals: impaired fasting glucose re-visited. Diab Vasc Dis Res (2011) 0.85
Individuation of different metabolic phenotypes in normal glucose tolerance test. Acta Diabetol (2009) 0.77
Expanding the clinical use of standard OGTT: the percentage increment of 2 h with respect to fasting glucose as an index of β-cell dysfunction. Diabetes Metab Res Rev (2011) 0.77